GSC inhibitors are a class of chemical compounds that target Goosecoid (GSC), a homeobox transcription factor involved in the regulation of embryonic development, particularly in the formation of body axes and organogenesis. GSC plays a key role in controlling the expression of genes that are critical for mesodermal and neural development. It acts as a transcriptional repressor, regulating various signaling pathways that guide cell fate determination, tissue differentiation, and morphogenetic movements during early development. Inhibitors of GSC disrupt its ability to bind to DNA and regulate gene expression, thus affecting the cellular processes and developmental pathways that rely on precise control of gene activation and repression.
The mechanism of action of GSC inhibitors generally involves binding to the DNA-binding domain of the GSC protein, preventing it from interacting with its target gene sequences or with other regulatory proteins essential for transcriptional repression. By inhibiting GSC function, these compounds can alter the transcriptional landscape within cells, disrupting normal patterns of gene expression that are crucial for development. Researchers utilize GSC inhibitors to study the molecular mechanisms by which GSC regulates embryonic patterning and how disruptions in its function affect cellular differentiation and tissue formation. These inhibitors provide valuable insights into the role of transcription factors in orchestrating complex developmental processes and offer a deeper understanding of the regulatory networks that control early embryogenesis and the establishment of body plans.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $91.00 $255.00 | 32 | |
Alkylating agent that interferes with DNA replication, leading to cell cycle arrest and apoptosis, potentially inhibiting GSC proliferation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src kinase inhibitor that disrupts multiple signaling pathways involved in cell proliferation and survival, potentially inhibiting GSC growth. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that disrupts protein degradation pathways, leading to cell cycle arrest and apoptosis, potentially inhibiting GSC growth. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multi-kinase inhibitor that targets RAF/MEK/ERK signaling, angiogenesis, and receptor tyrosine kinases, potentially inhibiting GSC proliferation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that disrupts cell signaling pathways involved in cell growth and proliferation, potentially inhibiting GSC proliferation. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Pan-histone deacetylase inhibitor that alters gene expression and induces apoptosis, potentially inhibiting GSC survival and proliferation. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR tyrosine kinase inhibitor that disrupts downstream signaling pathways, potentially suppressing GSC proliferation and survival. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
BCR-ABL tyrosine kinase inhibitor that blocks multiple signaling pathways, potentially inhibiting GSC growth and survival. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
DHODH inhibitor that disrupts pyrimidine synthesis, potentially affecting DNA replication and inhibiting GSC proliferation. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Platinum-based chemotherapeutic agent that forms DNA adducts, inducing DNA damage and apoptosis, potentially inhibiting GSC growth. | ||||||